207
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics

, , , , , , & show all
Pages 347-353 | Received 14 Dec 2015, Accepted 09 Aug 2016, Published online: 07 Nov 2016

References

  • World Health Organization (WHO). WHO alliance for the global elimination of blinding trachoma by the year 2020: progress report on elimination of trachoma, 2013. Weekly Epidemiological Record, Number 39, 26 September 2014. Available from: http://www.who.int/wer/2013/wer8939.pdf?ua=1 ( accessed December 14, 2015).
  • Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 2009;93:563–568.
  • Burton MJ, Mabey DCW. The global burden of trachoma: a review. PLoS Negl Trop Dis 2009;3(10): e460.
  • Taylor HR, Burton MJ, Haddad D, et al. Trachoma. Lancet 2014;384(9960):2142–2152.
  • Evans JR, Solomon AW. Antibiotics for trachoma. Cochrane Database of Systematic Reviews 2011 March 16;(3):CD001860.
  • Cajas-Monson LC, Mkocha H, Munoz B, et al. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania. PLoS Negl Trop Dis 2011;5:e978.
  • West SK, Munoz BE, Mkocha H, et al. Risk of infection with Chlamydia trachomatis from migrants to communities undergoing mass drug administration for trachoma control. Ophthalmic Epidemiol 2015;22:170–175.
  • Shah NA, House J, Lakew T, et al. Travel and implications for the elimination of trachoma in Ethiopia. Ophthalmic Epidemiol 2010;17:113–117.
  • Stare D, Harding-Esch E, Munoz B, et al. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia. Ophthalmic Epidemiol 2011;18:20–29.
  • West SK, Rapoza P, Munoz B, et al. Epidemiology of ocular chlamydial infection in a trachoma-hyperendemic area. J Infect Dis 1991;163:752–756.
  • Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 2004;351(19):1962–1971.
  • Thylefors B, Dawson C, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987;65:477–483.
  • Dize L, West S, Quinn TC, et al. Pooling ocular swab specimens from Tanzania for testing by Roche Amplicor and Aptima Combo 2 assays for the detection of Chlamydia trachomatis: accuracy and cost-savings. Diagn Microbiol Infect Dis 2013;77:289–291.
  • Harding-Esch E, Edwards T, Mkocha H, et al., for the PRET Partnership. Trachoma prevalence and associated risk factors in the Gambia and Tanzania: baseline results of a cluster randomized controlled trial. PLoS Negl Trop Dis 2010;4(11):e861.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.